Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (219)
Quality standard (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (2)
Clinical guidelines (45)
Diagnostics guidance (6)
Health technology evaluations (3)
Highly specialised technologies guidance (8)
Interventional procedures guidance (63)
Medical technologies guidance (27)
NICE guidelines (57)
Public health guidelines (7)
Social care guidelines (9)
Technology appraisal guidance (186)
Apply filters
Showing 31 to 40 of 219
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2021 and 31/3/2023
Remove Last updated date between 1/4/2021 and 31/3/2023 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Optilume for treating recurrent bulbar urethral strictures
MTG73
29 November 2022
29 November 2022
GreenLight XPS for treating benign prostatic hyperplasia
MTG74
29 November 2022
29 November 2022
Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal)
TA845
29 November 2022
29 November 2022
Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal)
TA846
29 November 2022
29 November 2022
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal)
TA847
29 November 2022
29 November 2022
Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal)
TA844
24 November 2022
24 November 2022
Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal)
TA843
24 November 2022
24 November 2022
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA841
22 November 2022
22 November 2022
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)
TA842
22 November 2022
22 November 2022
Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal)
TA839
16 November 2022
16 November 2022
Previous page
1
2
3
Current page
4
5
6
…
22
Page
4
of
22
Next page
Results per page
10
25
50
All
Back to top